Incannex Healthcare (IXHL) Retained Earnings (2020 - 2026)
Incannex Healthcare (IXHL) posted quarterly Retained Earnings of $253.2 million for Q1 2026, up 85.03% year-on-year from $136.8 million in Q1 2025, and up 2.5% on a QoQ basis from $247.0 million in Q4 2025.
Incannex Healthcare (IXHL) Retained Earnings (2020 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Retained Earnings for 7 consecutive years, with $253.2 million the latest figure, recorded in Q1 2026.
- Quarterly Retained Earnings rose 85.03% year-over-year to $253.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $253.2 million (up 85.03% YoY) and the FY2025 annual result came in at $174.0 million, up 39.0% from the prior year.
- Retained Earnings grew to $253.2 million in Q1 2026 per IXHL's latest filing, from $247.0 million in the prior quarter.
- Over the last five years, Retained Earnings for IXHL reached as high as $253.2 million in Q1 2026 and fell as low as -$67.3 million in Q4 2022.
- A 5-year average of $128.0 million and a median of $125.7 million in 2024 frame the typical range for Retained Earnings.
- Annual changes were most pronounced in 2022 — Retained Earnings slumped 33.96% — and 2023, when it jumped 297.79%.
- Year by year, Retained Earnings stood at -$67.3 million in 2022, then jumped by 278.07% to $119.9 million in 2023, then rose by 5.39% to $126.4 million in 2024, then soared by 95.52% to $247.0 million in 2025, then grew by 2.5% to $253.2 million in 2026.
- According to Business Quant data, Retained Earnings over the past three periods registered $253.2 million, $247.0 million, and $243.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 37.04 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 28.20 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 1.11 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 4.54 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 8.83 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | -1.81 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 18.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 589.60 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.13 Bn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 253.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 253.22 Mn |
| Dec 31, 2025 | 247.04 Mn |
| Sep 30, 2025 | 243.84 Mn |
| Jun 30, 2025 | 174.05 Mn |
| Mar 31, 2025 | 136.85 Mn |
| Dec 31, 2024 | 126.35 Mn |
| Sep 30, 2024 | 125.68 Mn |
| Jun 30, 2024 | 125.22 Mn |
| Mar 31, 2024 | 122.00 Mn |
| Dec 31, 2023 | 119.89 Mn |
| Jun 30, 2023 | 116.29 Mn |
| Dec 31, 2022 | -67.32 Mn |
| Jun 30, 2022 | -58.79 Mn |
| Jun 30, 2021 | -43.89 Mn |
| Jun 30, 2020 | -32.52 Mn |